13.07.2015 Views

Annual Report 2011 - Analist.be

Annual Report 2011 - Analist.be

Annual Report 2011 - Analist.be

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

3. Total, GDF SUEZ, Pernod Ricard, Suez Environnement, I<strong>be</strong>rdrola, Arkemaand other available-for-sale investments3.1. Net dividendsIn EUR million <strong>2011</strong> 2010 2009Total 251.7 204.8 200.8GDF SUEZ 175.8 175.8 257.7Pernod Ricard 37.6 34.8 11.4Suez Environnement 22.8 22.8 22.8I<strong>be</strong>rdrola 7.9 10.7 8.6Arkema 3.8 1.4 1.4Other 0.7 0.4 47.6Total 500.3 450.7 550.3In <strong>2011</strong>, GBL registered EUR 500 million in dividends (EUR 451 million en 2010). This EUR 49 million increase resulted mainlyfrom Total’s new quarterly dividend payout policy: Total’s third interim dividend for <strong>2011</strong>, decided in Octo<strong>be</strong>r <strong>2011</strong> (payablein March 2012), will <strong>be</strong> recorded in the accounts for 2012. Excluding this element, dividends were stable in <strong>2011</strong> and 2010.The amount of EUR 550 million registered in 2009 included the exceptional GDF SUEZ distribution of EUR 94 million and theone-time reimbursement of EUR 48 million in withholding at the source on previous dividends.3.2. Earnings on disposals and impairments on available-for-sale investmentsIn EUR million <strong>2011</strong> 2010 2009Impairments on available-for-sale investments - (20.4) (234.7)Pernod Ricard - - (198.2)I<strong>be</strong>rdrola - (20.4) (36.5)Capital gains on AFS shares 10.6 - -I<strong>be</strong>rdrola 10.6 - -Other 34.2 1.6 (23.6)Funds 35.6 3.6 (19.1)Other (1.4) (2.0) (4.5)Total 44.8 (18.8) (258.3)Accounts at 31 Decem<strong>be</strong>r <strong>2011</strong>Impairments on available-for-sale investmentsIn the context of the downturn of financial markets, GBL recorded, in compliance with IFRS requirements, EUR 255 millionin impairments in 2009 and 2010 on its investments in Pernod Ricard and I<strong>be</strong>rdrola, of which EUR 235 million in 2009 andEUR 20 million in 2010. The impairments recorded corresponded to the difference <strong>be</strong>tween the acquisition cost and the shareprice on closing date.Capital gains on available-for-sale sharesIn <strong>2011</strong>, GBL disposed of part of its investment in I<strong>be</strong>rdrola at a sale price of more than EUR 90 million, resulting in a capital gainof EUR 11 million. GBL still held 0.2% of I<strong>be</strong>rdrola on 31 Decem<strong>be</strong>r <strong>2011</strong>.OtherWith regard to the private equity funds, Sagard and PAI Europe III contributed EUR 17 million and EUR 19 million respectivelyin <strong>2011</strong> (compared to EUR 0 million and EUR 4 million in 2010).As a reminder, GBL’s investments are held through companies established in countries which, in principle, do not tax capitalgains on these investments.<strong>Annual</strong> <strong>Report</strong> <strong>2011</strong> 89

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!